| 書目名稱 | Pharmaceutical Regulatory Environment | | 副標(biāo)題 | Challenges and Oppor | | 編輯 | Reem K. Al-Essa,Mohammed Al-Rubaie,Sam Salek | | 視頻video | http://file.papertrans.cn/746/745548/745548.mp4 | | 概述 | Examines the regulatory review practices in the seven Gulf Cooperation Council states, namely Kuwait, Iraq, Bahrain, Oman, Qatar, Saudi Arabia and the United Arab Emirates.Compares national metrics wi | | 圖書封面 |  | | 描述 | .This book compares national and centralised procedure practices and key performance metrics, including current approval times, review practices and pharmacovigilance standards, in the seven Gulf States. Opportunities for an improved regulatory system are identified, which, if fully implemented, could have a significant impact on patients’ access to new medicines..The Persian Gulf represents the next growth market for the global biopharmaceutical industry but to date there has been limited information about the regulatory review processes employed in these countries. A thorough examination of the strategies currently being implemented by the Gulf States is considered critical to the future regulatory environment in this region..Pharmaceutical Regulatory Environment: Challenges & Opportunities in the Gulf Region. is a must read for those interested in pharmaceutical regulation in the Gulf region.. | | 出版日期 | Book 2015 | | 關(guān)鍵詞 | Harmonized centralized review procedure; Market approval for new drugs; National metrics; Regulatory re | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-319-17590-4 | | isbn_softcover | 978-3-319-36010-2 | | isbn_ebook | 978-3-319-17590-4 | | copyright | Springer International Publishing Switzerland 2015 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-26 05:37
發(fā)表于 2025-3-21 18:16:29
